The Blood Bank Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Whole Blood, Red Blood Cells, Platelet, Plasma, White Blood Cells), By Function (Collection, Processing, Testing, Storage, Transportation), By Bank (Private, Public), By End-User (Hospital, Ambulatory Surgery Centers, Pharmaceutical Companies, Clinics, Others).
In 2024, the market for blood banks plays a crucial role in ensuring a safe and adequate blood supply for transfusion therapy, emergency medical care, and surgical procedures, offering centralized facilities for blood collection, testing, storage, and distribution. Blood banks adhere to strict regulatory standards and quality assurance protocols to screen blood donors, perform serological and molecular testing for infectious diseases, and process blood components, including red blood cells, platelets, and plasma, for transfusion into patients with medical conditions or surgical needs. With a focus on blood safety, inventory management, and donor recruitment, blood banks utilize advanced technologies, including automation, barcoding, and cold chain management systems, to optimize blood supply chain logistics and ensure timely access to lifesaving blood products. Moreover, with advancements in blood typing, pathogen inactivation, and personalized transfusion medicine, the blood bank market continues to innovate, addressing emerging challenges and enhancing patient care in transfusion medicine and healthcare systems worldwide.
A significant trend in the blood bank market is the rising demand for blood and blood components due to various factors such as an aging population, increasing incidence of chronic diseases, and rising number of surgeries and trauma cases. Blood and its components are essential for various medical procedures, including surgeries, treatments for cancer and other diseases, and emergency care. Additionally, the expansion of healthcare infrastructure and the growing awareness about the importance of blood donation have contributed to the increasing demand for blood products. This trend underscores the importance of efficient blood bank operations and robust inventory management systems to meet the growing needs of patients and healthcare facilities, driving market growth and innovation in the blood bank sector.
A key driver for the blood bank market is the continuous advancements in transfusion medicine, including improvements in blood processing, storage, and testing technologies. Transfusion medicine plays a critical role in ensuring the safety, efficacy, and availability of blood and blood products for transfusion therapy. Advancements in blood banking technologies, such as automated blood processing systems, leukoreduction filters, and nucleic acid testing for infectious disease screening, have enhanced the quality and safety of blood products while reducing the risk of transfusion-transmitted infections. Additionally, the development of specialized blood products, such as frozen plasma, platelet concentrates, and red cell components, has enabled tailored treatment approaches for specific patient populations and medical conditions. As transfusion medicine continues to evolve with ongoing research and technological innovation, the blood bank market is poised for further growth and diversification to meet the evolving needs of healthcare providers and patients.
An opportunity in the blood bank market lies in the expansion into cellular therapies and regenerative medicine products derived from blood components, such as hematopoietic stem cells and platelet-rich plasma. Cellular therapies, including stem cell transplantation, immunotherapy, and cell-based regenerative therapies, hold immense promise for treating a wide range of diseases and injuries, including cancer, autoimmune disorders, and tissue damage. Blood banks can leverage their expertise in blood collection, processing, and storage to support the development and commercialization of cellular therapy products. By expanding into cellular therapies and regenerative medicine, blood banks can diversify their product offerings, tap into new revenue streams, and contribute to advancements in personalized medicine and regenerative therapies. Additionally, partnerships and collaborations with biotechnology companies, research institutions, and healthcare providers can facilitate the development and adoption of cellular therapy products, positioning blood banks as key players in the emerging field of regenerative medicine.
Platelet products stand out as a segment with rapid growth within the blood bank market. Platelets play a crucial role in blood clotting and are in high demand for various medical procedures, including surgeries, cancer treatments, and trauma care. The increasing prevalence of chronic diseases, such as cancer and hematological disorders, along with rising surgical procedures globally, is fueling the demand for platelet products. Additionally, advancements in blood processing and storage technologies have improved the availability and shelf life of platelet products, further driving market growth. Moreover, the growing awareness about platelet donation and initiatives by healthcare organizations to encourage voluntary blood donation are contributing to the expansion of this segment. As a result, platelet products are anticipated to witness significant growth in the coming years, making them a lucrative opportunity for stakeholders in the blood bank market.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAmerican Association of Blood Banks (AABB), Australian Red Cross, Bio-Rad Laboratories Inc, Blood Bank of Alaska, Canadian Blood Services (CBS), Fresenius Kabi AG, Haemonetics Corp, Macopharma, Ortho Clinical Diagnostics, Terumo BCT
By Product
Whole Blood
Red Blood Cells
Platelet
Plasma
White Blood Cells
By Function
Collection
Processing
Testing
Storage
Transportation
By Bank
Private
Public
By End-User
Hospital
Ambulatory Surgery Centers
Pharmaceutical Companies
Clinics
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
American Association of Blood Banks (AABB)
Australian Red Cross
Bio-Rad Laboratories Inc
Blood Bank of Alaska
Canadian Blood Services (CBS)
Fresenius Kabi AG
Haemonetics Corp
Macopharma
Ortho Clinical Diagnostics
Terumo BCT
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Blood Bank Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Blood Bank Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Blood Bank Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Blood Bank Market Size Outlook, $ Million, 2021 to 2030
3.2 Blood Bank Market Outlook by Type, $ Million, 2021 to 2030
3.3 Blood Bank Market Outlook by Product, $ Million, 2021 to 2030
3.4 Blood Bank Market Outlook by Application, $ Million, 2021 to 2030
3.5 Blood Bank Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Blood Bank Industry
4.2 Key Market Trends in Blood Bank Industry
4.3 Potential Opportunities in Blood Bank Industry
4.4 Key Challenges in Blood Bank Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Blood Bank Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Blood Bank Market Outlook by Segments
7.1 Blood Bank Market Outlook by Segments, $ Million, 2021- 2030
By Product
Whole Blood
Red Blood Cells
Platelet
Plasma
White Blood Cells
By Function
Collection
Processing
Testing
Storage
Transportation
By Bank
Private
Public
By End-User
Hospital
Ambulatory Surgery Centers
Pharmaceutical Companies
Clinics
Others
8 North America Blood Bank Market Analysis and Outlook To 2030
8.1 Introduction to North America Blood Bank Markets in 2024
8.2 North America Blood Bank Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Blood Bank Market size Outlook by Segments, 2021-2030
By Product
Whole Blood
Red Blood Cells
Platelet
Plasma
White Blood Cells
By Function
Collection
Processing
Testing
Storage
Transportation
By Bank
Private
Public
By End-User
Hospital
Ambulatory Surgery Centers
Pharmaceutical Companies
Clinics
Others
9 Europe Blood Bank Market Analysis and Outlook To 2030
9.1 Introduction to Europe Blood Bank Markets in 2024
9.2 Europe Blood Bank Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Blood Bank Market Size Outlook by Segments, 2021-2030
By Product
Whole Blood
Red Blood Cells
Platelet
Plasma
White Blood Cells
By Function
Collection
Processing
Testing
Storage
Transportation
By Bank
Private
Public
By End-User
Hospital
Ambulatory Surgery Centers
Pharmaceutical Companies
Clinics
Others
10 Asia Pacific Blood Bank Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Blood Bank Markets in 2024
10.2 Asia Pacific Blood Bank Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Blood Bank Market size Outlook by Segments, 2021-2030
By Product
Whole Blood
Red Blood Cells
Platelet
Plasma
White Blood Cells
By Function
Collection
Processing
Testing
Storage
Transportation
By Bank
Private
Public
By End-User
Hospital
Ambulatory Surgery Centers
Pharmaceutical Companies
Clinics
Others
11 South America Blood Bank Market Analysis and Outlook To 2030
11.1 Introduction to South America Blood Bank Markets in 2024
11.2 South America Blood Bank Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Blood Bank Market size Outlook by Segments, 2021-2030
By Product
Whole Blood
Red Blood Cells
Platelet
Plasma
White Blood Cells
By Function
Collection
Processing
Testing
Storage
Transportation
By Bank
Private
Public
By End-User
Hospital
Ambulatory Surgery Centers
Pharmaceutical Companies
Clinics
Others
12 Middle East and Africa Blood Bank Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Blood Bank Markets in 2024
12.2 Middle East and Africa Blood Bank Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Blood Bank Market size Outlook by Segments, 2021-2030
By Product
Whole Blood
Red Blood Cells
Platelet
Plasma
White Blood Cells
By Function
Collection
Processing
Testing
Storage
Transportation
By Bank
Private
Public
By End-User
Hospital
Ambulatory Surgery Centers
Pharmaceutical Companies
Clinics
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
American Association of Blood Banks (AABB)
Australian Red Cross
Bio-Rad Laboratories Inc
Blood Bank of Alaska
Canadian Blood Services (CBS)
Fresenius Kabi AG
Haemonetics Corp
Macopharma
Ortho Clinical Diagnostics
Terumo BCT
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Whole Blood
Red Blood Cells
Platelet
Plasma
White Blood Cells
By Function
Collection
Processing
Testing
Storage
Transportation
By Bank
Private
Public
By End-User
Hospital
Ambulatory Surgery Centers
Pharmaceutical Companies
Clinics
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Blood Bank Market is one of the lucrative growth markets, poised to register a 5.1% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
American Association of Blood Banks (AABB), Australian Red Cross, Bio-Rad Laboratories Inc, Blood Bank of Alaska, Canadian Blood Services (CBS), Fresenius Kabi AG, Haemonetics Corp, Macopharma, Ortho Clinical Diagnostics, Terumo BCT
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume